As of 10:43:29 GMT-5. Market open. Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week studyEpisodes of pericarditis per year substantially reduced ...
A downtrend has been apparent in Cardiol Therapeutics Inc. (CRDL) lately. While the stock has lost 6.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in ...
Hosted on MSN
HC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy Recommendation
Fintel reports that on June 2, 2025, HC Wainwright & Co. initiated coverage of Cardiol Therapeutics (NasdaqCM:CRDL) with a Buy recommendation. Analyst Price Forecast Suggests 475.44% Upside As of May ...
What is the current share price of Cardiol Therapeutics (CRDL)? Cardiol Therapeutics's (CRDL) current share price is $1.06. This constitutes a price movement of 4.50% when compared to the share price ...
(MENAFN- GetNews) $CRDL Target Recruitment Anticipated by End of Q2 2026, with Potential to Extend into Q3 to Accommodate Enrollment from Additional Clinical Sites ...
Get the latest Cardiol Therapeutics Inc. (CRDL) stock news and headlines to help you in your trading and investing decisions.
MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected to run concurrently with the Company's planned ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results